Pfizer Inc. and Metsera, Inc. announced that they have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company...
PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced an expansion of their partnership with Pfizer. The parties will launch...
Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract,...
Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, announced a newly expanded, multi-year agreement with global biopharmaceutical leader Pfizer to help...